| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 02/12/2015 | US20150045739 Method for treating otic infections after tympanostomy tube placement |
| 02/12/2015 | US20150045610 Method of modifying spermatogenesis, spermiogenesis and/or fertility in mammals |
| 02/12/2015 | US20150045416 Methods and Compositions for Gene Delivery |
| 02/12/2015 | US20150045410 Method of regulating cftr expression and processing |
| 02/12/2015 | US20150045406 Curaxins for use in treating breast cancer and method for identifing patients likely to respond |
| 02/12/2015 | US20150045405 CRYSTALLINE N--5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride |
| 02/12/2015 | US20150045403 Pharmaceutical Cream Compositions and Methods of Use |
| 02/12/2015 | US20150045401 Prodrugs of riluzole and their method of use |
| 02/12/2015 | US20150045400 Ritonavir compositions |
| 02/12/2015 | US20150045398 ArylSulfonamide-Based Matrix Metalloprotease Inhibitors |
| 02/12/2015 | US20150045396 Prophylactic or therapeutic agent for giant cell tumors occurring in bone and soft tissue or for chondrosarcoma |
| 02/12/2015 | US20150045374 2- (tert - butoxy) -2- (7 -methylquinolin- 6 - yl) acetic acid derivatives for treating aids |
| 02/12/2015 | US20150045364 Pyridine and Pyrazine derivative for the Treatment of CF |
| 02/12/2015 | US20150045357 Small molecule inhibitors of mcl-1 and uses thereof |
| 02/12/2015 | US20150045344 4-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereof |
| 02/12/2015 | US20150045342 Novel piperidine compound or salt thereof |
| 02/12/2015 | US20150045340 Amidine substituted beta-lactam compounds, their preparation and use as antibacterial agents |
| 02/12/2015 | US20150045337 Controlled release compositions and their methods of use |
| 02/12/2015 | US20150045332 Novel Sphingosine 1-Phosphate Receptor Antagonists |
| 02/12/2015 | US20150045326 Novel pyrazine amide compounds |
| 02/12/2015 | US20150045324 Novel fused pyrimidine derivatives for inhibition of tyrosine kinase activity |
| 02/12/2015 | US20150045306 Determination of single nucleotide polymorphisms useful to predict response for glatiramer acetate |
| 02/12/2015 | US20150044316 Method for preparing a purified extract of lonicera japonica thunberg and the composition comprising the same for preventing and treating sepsis and septic shock |
| 02/12/2015 | US20150044314 Pomegranate Oil For Preventing And Treating Neurodegenerative Diseases |
| 02/12/2015 | US20150044302 Compositions and methods for promoting appetite suppression using alkali metals |
| 02/12/2015 | US20150044296 Combination therapy to improve joint, tendon, and ligament healing |
| 02/12/2015 | US20150044280 Treatment methods using adenovirus |
| 02/12/2015 | US20150044278 Methods and compositions for the treatment of proliferative disorders |
| 02/12/2015 | US20150044270 Sustained delivery of therapeutic agents to an eye compartment |
| 02/12/2015 | US20150044261 Fatty Acid Conjugates of Quetiapine, Process for Making and Using the Same |
| 02/12/2015 | US20150044240 P53 vaccines for the treatment of cancers |
| 02/12/2015 | US20150044233 Ganglioside gd2 as a marker and target on cancer stem cells |
| 02/12/2015 | US20150044230 Methods related to tim 3, a th1-specific cell surface molecule, for activating antigen presenting cells |
| 02/12/2015 | US20150044229 Methods related to tim 3, a th1-specific cell surface molecule, for activating antigen presenting cells |
| 02/12/2015 | US20150044221 Pharmaceutical composition for treatment and/or prevention of cancer |
| 02/12/2015 | US20150044217 Methods for the treatment of her2 amplified cancer |
| 02/12/2015 | US20150044209 SOLUBLE IGF RECEPTOR Fc FUSION PROTEINS AND USES THEREOF |
| 02/12/2015 | US20150044207 Clotting Factor-Fc Chimeric Proteins to Treat Hemophilia |
| 02/12/2015 | US20150044203 Methods For Increasing Forced Expiratory Volume In Asthmatics Using Benralizumab |
| 02/12/2015 | US20150044201 Cyclon expression for the identification and control of cancer cells |
| 02/12/2015 | US20150044200 Treatment of tinnitus through modulation of chloride co-transporter nkcc1 in the auditory system |
| 02/12/2015 | US20150044196 Compositions for Inhibiting Gene Expression and Uses Thereof |
| 02/12/2015 | US20150044188 Antiviral methods and compositions comprising probiotic bacterial molecules |
| 02/12/2015 | US20150044177 Treatment of amyotrophic lateral sclerosis using placental stem cells |
| 02/12/2015 | US20150044174 Composition for improving eye health |
| 02/12/2015 | US20150044169 Methods of treating a flaviviridae family viral infection, compositions for treating a flaviviridae family viral infection, and screening assays for identifying compositions for treating a flaviviridae family viral infection |
| 02/12/2015 | US20150044168 Treatment of Multiple Sclerosis With Anti-CD19 Antibody |
| 02/12/2015 | US20150044164 Methods of Treating Autoimmune Diseases |
| 02/12/2015 | US20150044148 Method for Treating Capillary Hemangiomas |
| 02/12/2015 | US20150044137 Neutralizing antibodies to hiv-1 and their use |
| 02/12/2015 | US20150044134 Compositions, methods and kits for treatment of cancer and autoimmune diseases |
| 02/11/2015 | EP2835424A1 DNA CONTROLLING miR-140 EXPRESSION, AND SCREENING METHOD OF DRUGS USING SAID DNA |
| 02/11/2015 | EP2833917A1 Tyrosine kinase inhibitor combinations and their use |
| 02/11/2015 | EP2833915A1 Dosage and administration of monospecific and bispecific anti-igf-1r and anti-erbb3 antibodies |
| 02/11/2015 | EP2833883A1 Novel compositions of combinations of non-covalent dna binding agents and anti-cancer and/or anti-inflammatory agents and their use in disease treatment |
| 02/11/2015 | EP2833873A1 Film tablet formulations comprising cefuroxime axetil and clavulanic acid |
| 02/11/2015 | CN104349790A 用于治疗糖尿病的葡萄糖激酶活化剂组合物 For treating diabetes glucokinase activator composition |
| 02/11/2015 | CN104342479A 半乳糖凝集素-7产生抑制剂 Galectin inhibitor produced -7 |
| 02/11/2015 | CN104342375A 一种白念珠菌smt3基因的用途及缺失smt3基因的白念珠菌减毒株 An albicans use smt3 gene and gene deletion smt3 attenuated strain of C. albicans |
| 02/11/2015 | CN104338138A 一种聚合物包埋亲水性抗肿瘤药物复合粒子的制备方法 A process for preparing anti-tumor drugs entrapped hydrophilic polymer composite particles |
| 02/11/2015 | CN104338137A 增强治疗急性卒中之抗血小板药物之递送方法及其组合物 Enhanced delivery method for the treatment of acute stroke of antiplatelet drugs and combinations thereof |
| 02/11/2015 | CN104338136A 用于治疗的gm-csf和il-17抑制剂 For the treatment of gm-csf and il-17 inhibitor |
| 02/11/2015 | CN104338135A 抑郁症的调节因子及其应用 Adjustment factor for depression and its application |
| 02/11/2015 | CN104338134A 一种自噬抑制剂与精氨酸酶药物复合物及其用途 A self-macrophage arginase inhibitor drug complexes and their uses |
| 02/11/2015 | CN104338133A 防治口鼻咽喉上呼吸道感染的嚼服药物组合物及其应用 Prevention and treatment of respiratory tract infections in the mouth and nose throat Juefu pharmaceutical compositions and applications |
| 02/11/2015 | CN104338132A 一种病毒免疫治疗药物复合物及其用途 A virus immunotherapeutic drug complexes and uses thereof |
| 02/11/2015 | CN103157111B 新组合以及含有其的药物组合物 New combinations and pharmaceutical compositions containing the same |
| 02/11/2015 | CN103007288B 改进的贮库制剂 Improved depot formulation |
| 02/10/2015 | US8952178 Thiophene derivatives |
| 02/10/2015 | US8952166 Inhibitors of the renal outer medullary potassium channel |
| 02/10/2015 | US8952158 Tricyclic compound and use thereof |
| 02/10/2015 | US8952055 Membrane fusion inhibitor |
| 02/10/2015 | US8952043 Benzoxepin PI3K inhibitor compounds and methods of use |
| 02/10/2015 | US8952039 Pyridone derivatives and their use in the treatment, ameloriation or prevention of a viral disease |
| 02/10/2015 | US8952028 Methods of treating chemoresistance and relapse in cancer cells |
| 02/10/2015 | US8952018 Pharmaceutical combination of MEK inhibitor and B-Raf inhibitors |
| 02/10/2015 | US8952015 Inhibitors of Bruton's tyrosine kinase |
| 02/10/2015 | US8952000 Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events |
| 02/10/2015 | US8951994 Method of treating Gaucher disease |
| 02/10/2015 | US8951990 Use of alkylated semi-synthetic glycosaminoglycosan ethers for the treatment of dental disorders |
| 02/10/2015 | US8951987 Certain compounds, compositions and methods |
| 02/10/2015 | US8951986 Salts of HIV inhibitor compounds |
| 02/10/2015 | US8951972 FGFR1 extracellular domain combination therapies for lung cancer |
| 02/10/2015 | US8951969 Compositions and methods for treating centrally mediated nausea and vomiting |
| 02/10/2015 | US8951968 Methods of treating depression and other related diseases |
| 02/10/2015 | US8951965 Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
| 02/10/2015 | US8951747 Method for modulating activity of T lymphocytes |
| 02/10/2015 | US8951580 Methods for improving the safety of treating pediatric patients who are candidates for inhaled nitric oxide treatment |
| 02/10/2015 | US8951572 Therapeutic transplantation using developing, human or porcine, renal or hepatic, grafts |
| 02/10/2015 | US8951564 Galenic form suitable for absorbing, in a specific manner, the undesirable molecules in the digestive tract |
| 02/10/2015 | US8951551 Multiribbon nanocellulose as a matrix for wound healing |
| 02/10/2015 | US8951543 Nano silver—zinc oxide composition |
| 02/10/2015 | US8951538 Exopolysaccharide of Shigella sonnei bacteria, method for producing same, vaccine and phamaceutical composition containing same |
| 02/10/2015 | US8951536 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 02/10/2015 | US8951514 Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels |
| 02/10/2015 | CA2600350C Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
| 02/05/2015 | WO2015017803A1 Compositions and methods for treating disease states associated with activated t cells and/or b cells |
| 02/05/2015 | WO2015016392A1 New causative gene for amyotrophic lateral sclerosis |
| 02/05/2015 | WO2015016282A1 Pharmaceutical composition for preventing or treating radiation-induced gastrointestinal syndrome |
| 02/05/2015 | WO2015015818A1 Composition for ameliorating metabolic disorders caused by diabetes |